PHAT - Phathom Pharmaceuticals GAAP EPS of -$0.76 beats by $0.14
2023-11-09 09:07:48 ET
More on Phathom Pharmaceuticals
- Following Up On Phathom Pharmaceuticals
- Phathom Pharmaceuticals gets FDA approval for Erosive GERD drug
- Phathom wins FDA nod for reformulated antibiotic
- Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals
- Historical earnings data for Phathom Pharmaceuticals
For further details see:
Phathom Pharmaceuticals GAAP EPS of -$0.76 beats by $0.14